Ezetimibe Impurity 39 | CAS 845790-38-7 - Request Quote
Ezetimibe Impurity 39
| SZ CAT No: | SZ-E026092 |
| CAS No | 845790-38-7 |
| Mol.F. | C11H11FO3 |
| Mol.Wt. | 210.2 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ezetimibe Impurity 39 is chemically 5-(3-Fluorophenyl)-5-oxopentanoic acid. Ezetimibe Impurity 39 is supplied with detailed characterization data compliant with regulatory guideline. Ezetimibe Impurity 39 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ezetimibe.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 845790-38-7
Purchase 845790-38-7
Order 845790-38-7
Enquire 845790-38-7
price of 845790-38-7
845790-38-7 Supplier
845790-38-7 Manufacturer
845790-38-7 Exporter
buy high quality Ezetimibe Impurity 39
Purchase Ezetimibe Impurity 39
Ezetimibe Impurity 39 suppliers
Ezetimibe Impurity 39 manufacturers
Ezetimibe Impurity 39 price
Order Ezetimibe Impurity 39
Enquire Ezetimibe Impurity 39
Ezetimibe Impurity 39 cost
Ezetimibe Impurity 39 Supplier
Ezetimibe Impurity 39 Distributor
Ezetimibe Impurity 39 for Method Validation
Ezetimibe Reference Standard
Ezetimibe Impurity 39 for ANDA Filing
Ezetimibe Impurity 39 for Forced Degradation Studies
Ezetimibe Impurity 39 Identification Standards
Ezetimibe Impurity 39 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.